Filgrastim 48million units/0.5ml solution for injection pre-filled syringes
NHS hospitals in England used £39,307,315 of indicative cost of Filgrastim 48million units/0.5ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 6.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Filgrastim 48million units/0.5ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Filgrastim 48million units/0.5ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £4,406,306 |
| The Clatterbridge Cancer Centre Nhs Ft | £2,323,148 |
| Sheffield Teaching Hospitals Nhs Trust | £1,192,956 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,155,123 |
| Oxford University Hospitals Nhs Ft | £1,039,893 |
| North West Anglia Nhs Foundation Trust | £851,011 |
| The Royal Marsden Nhs Foundation Trust | £847,626 |
| University College London Foundation Tr | £827,891 |
| Univ Hpls Bristol Nhs Foundation Trust | £818,035 |
| Imperial College Healthcare Nhs Trust | £813,836 |
The primary-care picture
Filgrastim is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Filgrastim medicine page.